Tim Demuth serves as Executive at PIERIS PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Tim Demuth has executed 1 insider transactions totaling $10.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 13, 2022 involved purchasing 6,000 shares valued at $10.3K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 13, 2022 | PIRS | $10.3K | Purchase | 6,000 | $1.71 | Discretionary |
Tim Demuth currently holds 6,000 shares of PIERIS PHARMACEUTICALS, INC. (PIRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tim Demuth has been a net buyer of PIRS stock. They have purchased $10.3K and sold $0 worth of shares.
Tim Demuth's most recent insider trade was on May 13, 2022, when they purchased 6,000 shares at $1.71 per share.
Get notified when new Form 4 filings are submitted